Home >

Welcome to ASCO Connection Discussion

LOGIN TO START A DISCUSSION
Molecular Oncology Tumor Board
ASCO University
Feb 10, 2016 9:49 AM
Read more to answer the following questions: 1) Choice for site of biopsy? LN vs. Bone and merits/pros/cons for tissue for molecular profiling vs. confirmation of distant recurrence? 2) Would you recommend clinical genetics consultation for BRCA testing?  Expanded panel testing? 3) What additional...
ASCO University
William K. Oh, MD
Jan 20, 2016 9:07 AM
Welcome to this discussion forum for the Locally Advanced Prostate Cancer ASCO Tumor Board. This course discussed a 54 year old African American man with a history of atrial fibrillation and myocardial infarction, had a coronary artery bypass in 2015. Ejection fraction is now at 45%. He has...
Practice
Arsh Singh, MD
Jan 18, 2016 1:00 PM
In a 33 y/o caucasian woman with T2N0 Her 2 Positive invasive ductal carcinoma (both by IHC and FISH), ER 50% and PR negative, is it okay to use AC followed by T along with herceptin and pertuzumab  in the neoadjuvant setting?
Molecular Oncology Tumor Board
ASCO University
Jan 13, 2016 9:19 AM
Read more to answer the following questions: 1) What are the pathologic features that distinguish PEComa from the much more common leiomyosarcoma? 2) What is the role for cytotoxic chemotherapy in the treatment of metastatic or unresectable PEComa? 3) Are there any particular genetic targets...
ASCO University
Robert Glynne-Jones, MBBS
Dec 22, 2015 11:32 AM
Welcome to this discussion forum for the Rectal Cancer ASCO Tumor Board.  This course discussed an 82-year-old active female without systemic disease who is found to have microcytic anemia and weight loss. No other symptomatology. No family history of cancer. On exam she has no abdominal masses. No...

Pages

Tweets from ASCO

Tweets from Oncology Community